Answering your questions about the omicron vaccine rollout

The spike in COVID numbers is also leading one major vaccine manufacturer to go back to the drawing board and work on a new formula, that will do a better job of protecting against the omicron variant. But the timing of the vaccine's rollout is creating some questions.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting